efficacy and safety of etranacogene dezaparvovec: first data from the phase 3 hope-b trial
Published 3 years ago • 30 plays • Length 5:25Download video MP4
Download video MP3
Similar videos
-
3:49
hope-b trial: etranacogene dezaparvovec shows promise in hemophilia b
-
5:33
liver safety case report from the phase 3 hope-b gene therapy trial in adults with hemophilia b
-
2:21
etranacogene dezaparvovec (aav5-padua hfix variant): two year data from a phase 2b trial
-
8:50
updates from the hope-b trial: etranacogene dezaparvovec in adults with hemophilia b
-
24:40
data from phase 3 gene therapy trial in hemophilia b patients very encouraging
-
10:21
haemophilia: rockstars and flying cars
-
8:08
an overview of pharmacologic treatment for hemophilia
-
4:49
hemophilia: are we close to a cure?
-
0:52
etranacogene dezaparvovec | hemgenix | first gene therapy drug | 3.2 million usd
-
5:34
steven pipe: etranacogene dezaparvovec gene therapy for hemophilia b
-
10:23
how the gene therapy for hemophilia b got fda approval (the hope-b trial)
-
4:20
steve pipe discusses the latest on etranacogene dezaparvovec (aav5-padua hfix variant)
-
23:28
gene therapy for treatment of hemophilia: an introduction to aav vector gene transfer
-
3:58
follow-up of patients with hemophilia b treated with fidanacogene elaparvovec aav gene therapy
-
6:20
follow-up on gene therapy (flt180a) achieving normal fix activity levels (b-amaze study)
-
3:17
gene therapy for hemophilia: efficacy and safety
-
2:21
gene therapy for hemophilia b found safe and effective in first phase iii trial
-
3:23
new approaches to hemophilia research
-
6:18
current update of clinical trials on gene therapy for hemophilia
-
1:07
first & only one-time gene therapy for hemophilia b approved!
-
6:27
amt-061 gene transfer in adults with hemophilia b: early results of a phase 2b trial